Characterising the role of TEX12 in centrosome and cilia development

MRC · United Kingdom government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

September 29, 2027
Response Due
Active
Status

Opportunity Overview

Cell division is a fundamental process critical for the growth, development, and reproduction of living organisms. In mammals, there are two distinct types of cell division, mitosis and meiosis. Mitosis allows us to regenerate somatic cells by generating two daughter cells identical to the mother cell. In contrast, meiosis is essential for sexual reproduction and is characterised by the reduction of chromosome number resulting in four genetically diverse haploid daughter cells. To achieve this meiotic cell division involves a series of synchronised chromosome movements culminating in genetic recombination which ensures the diversity of the species. The intricate nature of meiosis is delivered by a specialised synaptonemal complex structure generally assumed to have no biological function other than facilitating genomic rearrangements in meiosis. Consequently, synaptonemal complex proteins are believed to be silenced in healthy somatic cells to prevent genomic instability during mitosis.
However, when investigating the effects of losing a synaptonemal complex gene called TEX12 we unexpectedly observed abnormal brain development and obesity. These phenotypes can be associated with a set of disorders called ciliopathies characterised by defects in the structure and function of cilia. Cilia are small hair-like structures found on the surface of some cells where they play a key role in cellular processes such as sensing and passing on signals. This project will employ live cell imaging and gene editing to determine the role TEX12 plays in cilia formation. Furthermore, we will identify regulators of TEX12 expression to understand when it is normally produced outside of meiosis. This cross-disciplinary approach will allow us to characterise if TEX12 is one of the causes of ciliopathy in patients.

This is one of 1,833 active United Kingdom Research Development opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyMRC
CountryUnited Kingdom
CategoryResearch Development
PublishedSeptember 30, 2023
Procurement stageActive solicitation
Response dueSeptember 29, 2027
StatusOpen — accepting responses
Official sourceView original notice
Last verifiedAugust 10, 2026

Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.

Related Opportunities in United Kingdom

Rotation year
Title of project: Evaluation of the quantitative accuracy and radiation dosimetry of an advanced pre-clinical multipinhole SPECT/CT theranostic imag
Discerning MCT1s role in chromatin remodelling and metabolomics changes in cancer progression
Leveraging real world data to characterise the long term impact of COVID-19
Bacterial antibiotic resistance: structure, mechanism and inhibition of ABC transporters responsible for drug efflux and cell wall biogenesis.
Allogeneic Chondroprogenitor Therapy (Phase II) (ACT2)
Dectin-1-mediated suppression of protective anti-mycobacterial immunity
Iron and immunity

See every United Kingdom Research Development opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United Kingdom Research Development intelligence report in your inbox

A personalized report on United Kingdom Research Development opportunities, emailed in 5-10 minutes. One per month, no account needed.